[26-002079] nhlbi in-vivo gene therapy core, CAO lab, and remaley lab requires ultracentrifuge which will be used to separate, purify, and analyze very small particles such as proteins, nucleic acids,…
Ended Awarded Last action
- Contract number
- 75N92026F00032
- Awardee
-
Franklin Young International, Incorporated UEI EDQMKDZR8L13
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $79,432
Award facts
- Contract value 100% obligated
- $79,431.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Upland, CA 91786, USA
Award details come from SAM.gov/FPDS.
About this award
The National Heart Lung and Blood Institute (NHLBI) awarded a delivery order valued at $79,431.83 to Franklin Young International, Incorporated for the procurement of an ultracentrifuge to support the In-Vivo Gene Therapy Core, CAO Lab, and Remaley Lab. The ultracentrifuge will be utilized to separate, purify, and analyze extremely small particles including proteins, nucleic acids, viruses, and cell organelles based on their size—critical capabilities for advanced molecular and genetic research. The contract was awarded on January 6, 2026, with an ultimate completion date of April 6, 2026, and carries a firm fixed price structure. The equipment will be delivered to the NHLBI's facility in Upland, California. No set-aside designation was applied to this delivery order.
Franklin Young International, Incorporated is a Service-Disabled Veteran-Owned Small Business based in Upland, California, specializing in laboratory equipment and scientific products for federal agencies. The company maintains a substantial federal contract portfolio across multiple agencies including the National Institutes of Health, Department of Veterans Affairs, and Department of Agriculture, with contract values ranging from several hundred dollars to over $750,000. This delivery order falls under the company's Multiple Award Schedule (MAS) contract vehicle with the General Services Administration, enabling streamlined procurement of specialized scientific equipment to support critical research initiatives within the federal government.
Description
[26-002079] nhlbi in-vivo gene therapy core, CAO lab, and remaley lab requires ultracentrifuge which will be used to separate, purify, and analyze very small particles such as proteins, nucleic acids, viruses, and cell organelles based on their size
Quick answers
Who was awarded contract 75N92026F00032?
75N92026F00032 was awarded to Franklin Young International, Incorporated by National Heart Lung and Blood Institute (National Institutes of Health) on January 6, 2026.
How much is contract 75N92026F00032 worth?
The government has obligated $79,432 on 75N92026F00032.
Is contract 75N92026F00032 an order under another contract?
Yes. 75N92026F00032 is a delivery order under GS07F0636W, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75N92026F00032 competed?
The extent of competition for 75N92026F00032 was full and open competition. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award